For decades pharmaceutical companies have received profits in their industry that now make it the most profitable in the world. Seizing the opportunity created by the public outcry for the concern over the HIV/AIDS epidemic, big pharmaceutical companies lobbied for and crafted legislation to allow for the fast tracking of drugs. The Prescription Drug User Fee Act (PDUFA), with its fast tracking drug approval provisions has accounted for an increasing introduction of new drugs into the marketplace over the last twelve years. A natural result of shortening the time period in which to investigate is the dizzying number of drugs recalled from the market, and those for which the Food and Drug Administration must require more stringent warnings than the companies are willing to provide on their own. Additionally, the number of consumers injured by pharmaceutical products has risen since the change to fast tracking drugs.

Currently I am investigating cases involving Hormone Replacement Therapy, Guidant & Medtronic Heart Devices.  Some cases of current interest are:

Avandia
Crestor
Depo-Provera
ESA: Erythropoiesis Stimulating Agents
Fosamax
Gadolinium
General Pharmaceutical
Guidant Heart Devices
Heart Lead Recall
Hormone Replacement Therapy
Kugel Hernia Patch
Medtronic Heart Devices
Ortho Evra
Pain Pumps and PAGCL
Shelhigh Device Recall
Stevens Johnson Syndrome
Vytorin
Welding Rods
Zelnorm
Zetia
Zithromax

If you have been injured  by ingesting a drug, please contact my office for a free evaluation of your potential case.

CONTACT ATTORNEY RANDAL FORD by filling in your information below.